SCHEMBL6807438

SCHEMBL6807438

C=C(c1ccc(Cl)cc1)c1ccc(Cl)cc1Cl

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
CASP1 P29466 1/20 0.50
SRD5A2 P31213 1/20 0.49
RAB9A P51151 2/20 0.46
HPGD P15428 2/20 0.46
NPC1 O15118 1/20 0.46
CASP3 P42574 1/20 0.46
SENP7 Q9BQF6 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
ALDH1A1 P00352 1/20 0.46
MAPK1 P28482 1/20 0.46
HIF1A Q16665 1/20 0.46
MAPT P10636 2/20 0.45
KDM4E B2RXH2 1/20 0.44
GABRA1 P14867 3/20 0.42
GABRG2 P18507 3/20 0.42
GABRB3 P28472 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10704841 0.89 FLT1 (0.47) TSHRSMN1; SMN2CASP1SRD5A2RAB9A
SCHEMBL28668332 0.88 SMN1; SMN2 (0.52) TSHRSMN1; SMN2CASP1SRD5A2RAB9A
SCHEMBL10905142 0.85 CA1 (0.42) TSHRSMN1; SMN2CASP1SRD5A2RAB9A
SCHEMBL9592286 0.85 TSHR (0.44) TSHRSMN1; SMN2CASP1SRD5A2RAB9A
SCHEMBL2081053 0.82 TSHR (0.48) TSHRSMN1; SMN2CASP1SRD5A2RAB9A
SCHEMBL9590622 0.79 MEN1 (0.55) TSHRSMN1; SMN2CASP1SRD5A2RAB9A
SCHEMBL2933370 0.79 RAB9A (0.46) SMN1; SMN2RAB9AHPGDNPC1KMT2A
SCHEMBL10901306 0.78 KMT2A (0.56) TSHRSMN1; SMN2RAB9ANPC1MEN1
SCHEMBL331512 0.78 CA1 (0.52) TSHRSMN1; SMN2CASP1RAB9AHPGD
Hydrochloric Acid SCHEMBL27669623 0.78 RAB9A (0.45) SMN1; SMN2RAB9AHPGDNPC1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040147788-A1 Stilbene derivatives and their use as aryl hydrocarbon receptor antagonistic ligands INSTITUTE NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (I.N.S.E.R.M.) (FR) 2004-07-29 US claimed
EP-1418164-A1 New stilbene derivatives and their use as aryl hydrocarbon receptor ligand antagonists INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2004-05-12 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040147788-A1 Stilbene derivatives and their use as aryl hydrocarbon receptor antagonistic ligands AHR, HCAR3, HCAR1 TSHR 35/4885SMN1; SMN2 4212/4885CASP1 1015/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.